Your browser doesn't support javascript.
loading
A review on the efficacy and mechanism of action of Shenkang injection against chronic kidney disease.
Zou, Jun-Ju; Zhou, Xiao-Tao; Chen, Yan-Kun; Liu, Jia-Lu; Wang, Cheng; Ma, Yue-Rong; Wang, Li.
Afiliação
  • Zou JJ; School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
  • Zhou XT; School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
  • Chen YK; Hunan University of Chinese Medicine, Changsha, 410200, China.
  • Liu JL; School of Educational Science, Hunan Normal University, Changsha, 410006, China.
  • Wang C; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
  • Ma YR; School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China; Hunan University of Chinese Medicine, Changsha, 410200, China. Electronic address: mayr666@163.com.
  • Wang L; Department of Pathology, Affiliated Hospital of Chengdu University of Chinese Medicine, Chengdu, 611137, China. Electronic address: 120560896@qq.com.
Biomed Pharmacother ; 132: 110833, 2020 Dec.
Article em En | MEDLINE | ID: mdl-33035831
ABSTRACT
Chronic kidney disease (CKD) is one of the most common conditions which significantly increases the risk for serious health outcomes. Epidemiological investigations have shown that CKD has become a serious global health problem. At present, there are no treatments for CKD, thus the need for an effective and safe treatment for this condition. Shenkang Injection (SKI), which is an herbal medication in Chinese Medicine, has been used in the management and treatment of CKD and has achieved favorable therapeutic effects. The purpose of this paper is to review the clinical efficacy, mechanism of action, and safety profile of SKI when used in CKD, and to provide comprehensive potential evidence for its clinical application.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Insuficiência Renal Crônica Limite: Animals / Humans Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Insuficiência Renal Crônica Limite: Animals / Humans Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China